Evidence map›Paper›PMID 40225015›Full record

ArticleJournal of diabetes research2025

Causal Association Between Cholesterol-Lowering Drugs and Diabetic Microvascular Complications: A Drug-Target Mendelian Randomization Study.

Bo Yang, Bo Yao, Qu Zou, Sicheng Li, Shun Yang, Mengxue Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bo YangDepartment of Endocrinology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.ORCID https://orcid.org/0009-0009-3588-4946
Bo YaoDepartment of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.ORCID https://orcid.org/0000-0002-2193-2347
Qu ZouDepartment of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.ORCID https://orcid.org/0009-0000-8060-5314
Sicheng LiDepartment of Endocrinology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.ORCID https://orcid.org/0009-0005-2757-8835
Shun YangDepartment of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.ORCID https://orcid.org/0009-0006-4501-0968
Mengxue YangDepartment of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-2065-5886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anticholesteremic AgentsDiabetic AngiopathiesHydroxymethylglutaryl-CoA Reductase InhibitorsPCSK9 InhibitorsCholesterol, LDLDiabetic NephropathiesDiabetic RetinopathyGenome-Wide Association StudyHumansHydroxymethylglutaryl CoA ReductasesMembrane Transport ProteinsMendelian Randomization AnalysisPolymorphism, Single NucleotideProprotein Convertase 9Anticholesteremic AgentsCholesterol, LDLHMGCR protein, humanHydroxymethylglutaryl-CoA Reductase InhibitorsHydroxymethylglutaryl CoA ReductasesMembrane Transport ProteinsNPC1L1 protein, humanPCSK9 InhibitorsPCSK9 protein, humanProprotein Convertase 9cholesterol-loweringdiabetic nephropathydiabetic neuropathydiabetic retinopathyHMGCRLDL cholesterolMendelian randomizationNPC1L1PCSK9

Identifiers

PMID40225015
PMCPMC11986941

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.